The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
The RNS was intended to put good news out there as to the changing environment for pharma etc. unfortunately some read it as negative so this presentation should enhance the positive outlook.
Opportunity to smash it out the park and FAB arriving on many investors radars. Let’s hope so. Market cap minuscule for what they have.
Good pass on Hull thank you. A good find. I like the summary at the end which states,
‘PON-based fiber access is growing around the globe. There continues to be new, large opportunities for PON equipment and component vendors. In addition, POL is gaining momentum, reflecting PON’s penetration into the LAN market. The PON component and equipment market continues to be in the “growth” stage’.
And the hint at contracts in last RNS will land v soon imho. Ultra fast (see what I did there!) growth story.
I like towards the end of the interview where he states we are already in Phase 1 trials with everything going on. I read that as the prep and getting ready to start to start injecting patients which we all hope will provide a cure for these folk.
Recently raised circa £1.3 million at 4p. Market cap a micro £4 million and partnered with National Cancer Institute in US.
Sentiment towards small pharmas improving all the time so the right share in the right places is FAB. Easy 100% first up.
Wow! Great find Haywain.
As those of us who are here to support a company finding cures for terrible diseases such as claimed my beautiful sister recently and also making investors willing to risk their money enormous profits then this article tells it as it is.
The upside is truly phenomenal and is happening now. Personally taking ever y opportunity to buy more like into a monthly unit trust at these prices cause when it turns on news as the article rightly says the upside is going to be dramatic. Good luck all.
Just a thought. The CFO mentioned the circa 4 million in warrants that Riverfort have at various prices I think starting at 10p.
He mentioned these could be reviewed/adjusted so it could be the funding will come from River exercising their warrants at a lower price meaning the company gets their cash raise, River will dispose of their final shares and then away we go.
Lovely update thank you.
Market cap circa £5 million. Cash in bank £1.2 million so circa a quarter of market cap in cash.
A range of funding options being considered and cash to be used for FDA submission etc which will provide explosive growth. Rainbow chasers fail to look beyond the noise.
ATB to genuine investors.
JHFH - you took the words. Having just listened to it was going to make that point which is the strongest part of the interview for me.
He made clear how difficult funding had been for all small cap biotechs yet they got a good raise away and now investors and other ‘entities’ coming to them.
Can see a strategic investor/ JV being announced. Clinical trial company plus he also mentioned options to sell off parts. Imagine what the other two parts are each worth?!
IMHO - the rise to 6p recently will fade as this rockets. Watch this space. Bought some more thank you.
Cheadle - spot on but I would add this.
In the RNS announcing the collaboration with NCI USA there is minimal funds required from FAB and yet we have a whale of an institution willing to engage and get involved in the ONLY Optimal platform in the world!
Then look at the market cap and now cash positive then you and I see why the multibagger upside is approaching based on our research.
Onwards and very upwards.
So tomorrow is the 10am meeting to approve the increase in shares. This triggers the placing at 4p which raises circa £1.35 million. Add the recent tax credit at circa £280,000 and you have over £1.6 million in cash.
Market cap just over £2 million with tie up with National Cancer Institute of US. This is getting ready to re rate big time IMHO.
Good luck all.
I had so much faith in this company. Sold on recent spike to recover my money.
Just no end in sight to monetise the assets.
Can’t sell Microsalt for a year, BELL and LUCYD need time to recover and clear Guident continues to need funding and now a new company that clearly is going to need funds.
So corrupt that the price dropped over last few days then this placing.
Good luck to the faithful.
Just a thought…… Top 5 worldwide bakery companies…..
1. Nestle … net sales 94 billion dollars pa
2. PepsiCo (already rumoured as the company we supply) 86 billion
3.Arca continental Mexico (note we also been mentioned as involved in the country …53 billion
4. Mondelez International US …31 billion
5. Kraft Heinz … 26 billion
Wakey wakey market……Microsalt can produce anywhere in the world and at scale. Already with a whale and the others will not want to be left behind. Worth £3 plus even at this stage of growth. IMHO